chr11-34916150-T-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015957.4(APIP):​c.57+78A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.794 in 1,543,634 control chromosomes in the GnomAD database, including 487,612 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.79 ( 47695 hom., cov: 34)
Exomes 𝑓: 0.79 ( 439917 hom. )

Consequence

APIP
NM_015957.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.69
Variant links:
Genes affected
APIP (HGNC:17581): (APAF1 interacting protein) Enables identical protein binding activity; methylthioribulose 1-phosphate dehydratase activity; and zinc ion binding activity. Involved in several processes, including L-methionine salvage from methylthioadenosine; protein homotetramerization; and pyroptosis. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
PDHX (HGNC:21350): (pyruvate dehydrogenase complex component X) The pyruvate dehydrogenase (PDH) complex is located in the mitochondrial matrix and catalyzes the conversion of pyruvate to acetyl coenzyme A. The PDH complex thereby links glycolysis to Krebs cycle. The PDH complex contains three catalytic subunits, E1, E2, and E3, two regulatory subunits, E1 kinase and E1 phosphatase, and a non-catalytic subunit, E3 binding protein (E3BP). This gene encodes the E3 binding protein subunit; also known as component X of the pyruvate dehydrogenase complex. This protein tethers E3 dimers to the E2 core of the PDH complex. Defects in this gene are a cause of pyruvate dehydrogenase deficiency which results in neurological dysfunction and lactic acidosis in infancy and early childhood. This protein is also a minor antigen for antimitochondrial antibodies. These autoantibodies are present in nearly 95% of patients with the autoimmune liver disease primary biliary cirrhosis (PBC). In PBC, activated T lymphocytes attack and destroy epithelial cells in the bile duct where this protein is abnormally distributed and overexpressed. PBC eventually leads to cirrhosis and liver failure. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 11-34916150-T-C is Benign according to our data. Variant chr11-34916150-T-C is described in ClinVar as [Benign]. Clinvar id is 304443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.81 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
APIPNM_015957.4 linkuse as main transcriptc.57+78A>G intron_variant ENST00000395787.4
APIPXM_011520154.4 linkuse as main transcriptc.13+78A>G intron_variant
PDHXXM_011520390.2 linkuse as main transcriptc.-21+212T>C intron_variant
APIPXM_017017875.3 linkuse as main transcriptc.-301+78A>G intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
APIPENST00000395787.4 linkuse as main transcriptc.57+78A>G intron_variant 1 NM_015957.4 P1Q96GX9-1
PDHXENST00000448838.8 linkuse as main transcriptc.-357T>C 5_prime_UTR_variant 1/115
PDHXENST00000533550.5 linkuse as main transcriptc.-21+212T>C intron_variant 4
APIPENST00000527830.1 linkuse as main transcriptn.124+78A>G intron_variant, non_coding_transcript_variant 2

Frequencies

GnomAD3 genomes
AF:
0.791
AC:
120209
AN:
152060
Hom.:
47674
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.802
Gnomad AMI
AF:
0.871
Gnomad AMR
AF:
0.719
Gnomad ASJ
AF:
0.836
Gnomad EAS
AF:
0.831
Gnomad SAS
AF:
0.731
Gnomad FIN
AF:
0.770
Gnomad MID
AF:
0.790
Gnomad NFE
AF:
0.801
Gnomad OTH
AF:
0.775
GnomAD4 exome
AF:
0.794
AC:
1105020
AN:
1391456
Hom.:
439917
Cov.:
29
AF XY:
0.793
AC XY:
545101
AN XY:
687690
show subpopulations
Gnomad4 AFR exome
AF:
0.802
Gnomad4 AMR exome
AF:
0.642
Gnomad4 ASJ exome
AF:
0.834
Gnomad4 EAS exome
AF:
0.821
Gnomad4 SAS exome
AF:
0.746
Gnomad4 FIN exome
AF:
0.770
Gnomad4 NFE exome
AF:
0.802
Gnomad4 OTH exome
AF:
0.796
GnomAD4 genome
AF:
0.790
AC:
120272
AN:
152178
Hom.:
47695
Cov.:
34
AF XY:
0.788
AC XY:
58640
AN XY:
74376
show subpopulations
Gnomad4 AFR
AF:
0.802
Gnomad4 AMR
AF:
0.718
Gnomad4 ASJ
AF:
0.836
Gnomad4 EAS
AF:
0.831
Gnomad4 SAS
AF:
0.730
Gnomad4 FIN
AF:
0.770
Gnomad4 NFE
AF:
0.801
Gnomad4 OTH
AF:
0.767
Alfa
AF:
0.744
Hom.:
2241
Bravo
AF:
0.788
Asia WGS
AF:
0.750
AC:
2606
AN:
3472

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxJun 23, 2018- -
Pyruvate dehydrogenase E3-binding protein deficiency Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
6.2
DANN
Benign
0.50
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2016814; hg19: chr11-34937697; API